Accolade to Announce Fiscal Second Quarter 2025 Financial Results

Rhea-AI Summary

Accolade, Inc. (NASDAQ: ACCD) has announced the release date for its fiscal second quarter 2025 financial results. The company will disclose the results on Tuesday, October 8, 2024, before market open. Following the release, Accolade will host a conference call at 8:00 a.m. E.T. to review the results.

Interested parties can participate in the conference call via telephone by pre-registering through a provided link. Upon registration, participants will receive dial-in information and a unique PIN. Alternatively, a live audio webcast of the call will be accessible online at the company's investor relations website. For those unable to attend live, a replay of the call will be available for one year via webcast on the same website.

SEATTLE, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2025 financial results on Tuesday, October 8, 2024 before market open. In conjunction, the company will host a conference call to review results at 8:00 a.m. E.T. on the same day.

Conference Call Details

To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking here (https://register.vevent.com/register/BI0b6b999c6e7b47fdb26d7e8a774df09f). Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN.

To Listen via Internet: The conference call can be accessed via a live audio webcast that will be available online at http://ir.accolade.com .

Replay: A replay of the call will be available for one year via webcast for on-demand listening shortly after the completion of the call, at http://ir.accolade.com.

About Accolade, Inc.

Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com. Follow us on LinkedIn, Twitter, Instagram and Facebook.

Investor Contact:

Todd Friedman, Investor Relations, IR@accolade.com

Media Contact:

Media Inquiries, Media@accolade.com

Source: Accolade        

This press release was published by a CLEAR® Verified individual.

FAQ

When will Accolade (ACCD) release its Q2 2025 financial results?

Accolade (ACCD) will release its fiscal second quarter 2025 financial results on Tuesday, October 8, 2024, before the market opens.

How can investors participate in Accolade's (ACCD) Q2 2025 earnings call?

Investors can participate in Accolade's Q2 2025 earnings call by pre-registering for the telephone conference or accessing the live audio webcast on the company's investor relations website at 8:00 a.m. E.T. on October 8, 2024.

Will there be a replay available for Accolade's (ACCD) Q2 2025 earnings call?

Yes, a replay of Accolade's Q2 2025 earnings call will be available for one year via webcast on the company's investor relations website at http://ir.accolade.com.

What is the stock symbol for Accolade mentioned in the Q2 2025 earnings announcement?

The stock symbol for Accolade mentioned in the Q2 2025 earnings announcement is ACCD, traded on NASDAQ.